Characterization of novel ACE2 mRNA transcripts: The potential role of alternative splicing in SARS-CoV-2 infection

This publication has 64 references indexed in Scilit:

• Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
  Pharmacological Reports, 2022
• Time-Dependent COVID-19 Mortality in Patients With Cancer
  JAMA Oncology, 2021
• Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
  Medical Oncology, 2021
• Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting
  Inflammopharmacology, 2021
• The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19
  Heart Failure Reviews, 2021
• Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism
  Biochemical and Biophysical Research Communications, 2020
• Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike protein
  Journal of Medical Virology, 2020
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
  Cell, 2020
• Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
  Frontiers of Medicine, 2020
• Architecture and function of metallopeptidase catalytic domains
  Protein Science, 2013